Annual epidemiological report 2013 SURVEILLANCE REPORT (original) (raw)

List of tables Table A Overview of the number of reporting countries, reported cases, EU notification rates and Member States notification rates range, by disease, 1.1 Standard European mean population 2000-2010 used for calculation of age standardised rates 2.1.1 Number of sentinel detections of influenza virus by type, subtype and lineage from week 40/2011 to week 20/2012 in 29 EU/EEA countries 2.1.2 Antiviral resistance by influenza virus type and subtype, weeks 40/2011 to 20/2012 2.1.3 Numbers and rates of Legionnaires' disease cases reported in the EU/EEA, 2007-2011 2.1.4 Numbers and rates of reported tuberculosis cases (confirmed, probable and possible) per 100 000 population in the EU/EEA, 2007-2011 2.1.5 Numbers and percentage of multidrug-resistant and extensively drug-resistant tuberculosis cases, EU/ EEA, 2011 2.2.1 Numbers and rates of confirmed chlamydia cases reported in the EU/EEA, 2007-2011 2.2.2 Numbers and rates of gonorrhoea cases reported in the EU/EEA, 2007-2011 2.2.3 Numbers and rates of reported hepatitis B cases in the EU/EEA, 2008-2011 † 2.2.4 Numbers and rates of reported hepatitis C cases in the EU/EEA, 2008-2011 † 2.2.5 Numbers and rates of newly diagnosed HIV infections in the EU/EEA, 2004-2011 2.2.6 Numbers and rates of syphilis cases reported in the EU/EEA, 2007-2011 2.3.1 Numbers and rates of confirmed anthrax cases reported in the EU/EEA, 2007-2011 2.3.2 Numbers and rates of confirmed botulism cases reported in the EU/EEA, 2007-2011 2.3.3 Numbers and rates of confirmed brucellosis cases reported in the EU/EEA, 2007-2011 2.3.4 Numbers and rates of confirmed campylobacteriosis cases reported in the EU/EEA, 2007-2011 2.3.5 Numbers and rates of confirmed cholera cases reported in the EU/EEA, 2011 2.3.6 Numbers and rates of confirmed cryptosporidiosis cases reported in the EU/EEA, 2007-2011 2.3.7 Numbers and rates of confirmed echinococcosis cases reported in the EU/EEA, 2007-2011 2.3.8 Numbers and rates of confirmed STEC/VTEC cases reported in the EU/EEA, 2007-2011 2.3.9 Most commonly reported O-serogroups in confirmed STEC/VTEC cases, EU/EEA, 2011 2.3.10 Numbers and rates of confirmed giardiasis cases reported in the EU/EEA, 2007-2011 2.3.11 Numbers and rates of confirmed hepatitis A cases reported in the EU/EEA, 2007-2011 2.3.12 Numbers and rates of confirmed leptospirosis cases reported in the EU/EEA, 2007-2011 2.3.13 Numbers and rates of confirmed listeriosis cases reported in the EU/EEA, 2007-2011 2.3.14 Numbers and rates of confirmed salmonellosis cases reported in the EU/EEA, 2007-2011 2.3.15 Salmonella serotypes most frequently reported from EU/EEA countries in 2011 and percentage change, 2010-2011 2.3.16 Numbers and rates of confirmed shigellosis cases reported in the EU/EEA, 2007-2011 2.3.17 Proportion of confirmed cases of shigellosis reported in the EU/EEA, 2011, based on origin of infection (travel-associated/domestic) 2.3.18 Numbers and rates of confirmed congenital toxoplasmosis cases reported in the EU/EEA, 2007-2011 2.3.19 Numbers and rates of confirmed trichinellosis cases reported in the EU/EEA, 2007-2011 2.3.20 Number and rates of confirmed tularaemia cases reported in EU/EEA countries, 2007-2011 2.3.21 Numbers and rates of confirmed typhoid and paratyphoid cases reported in the EU/EEA, 2007-2011 2.3.22 Salmonella enterica serotypes of typhoid and paratyphoid fever cases reported in the EU/EEA, 2011 2.3.23 Numbers and rates of confirmed yersiniosis cases reported in the EU/EEA, 2007-2011 2.4.1 Numbers and rates of confirmed malaria cases reported in the EU/EEA, 2011 2.4.2 Numbers and rates of confirmed Q fever cases reported in the EU/EEA, 2011 2.4.3 Numbers and rates of hantavirus infection cases reported in the EU/EEA, 2007-2011 2.4.4 Numbers and rates of dengue fever cases reported in the EU/EEA, 2008-2011 2.4.5 Numbers and rates of chikungunya fever cases reported in the EU/EEA, 2008-2011 2.4.6 Numbers and rates of West Nile fever cases reported in the EU/EEA, 2011 2.5.1 Numbers and rates of diphtheria cases reported in the EU/EEA, 2007-2011 2.5.2 Number of diphtheria cases by pathogen and country, EU/EEA, 2011 2.5.3 Numbers and rates of confirmed invasive Haemophilus influenzae cases reported in the EU/EEA, 2007-2011 2.5.4 Numbers and rates of confirmed invasive meningococcal disease cases reported in the EU/EEA, 2007-2011 2.5.5 Numbers and rates of confirmed invasive pneumococcal cases reported in the EU/EEA, 2007-2011 2.5.6 Numbers and rates of measles cases reported in the EU/EEA, 2007-2011 xiii Annual epidemiological report SURVEILLANCE REPORT 2.5.7 Numbers and rates of cases of mumps reported in the EU/EEA, 2007-2011 2.5.8 Numbers and rates of total pertussis cases reported in the EU/EEA, 2007-2011 2.5.9 Numbers and rates of rubella cases reported in the EU/EEA, 2007-2011 2.5.10 Numbers and rates of tetanus cases reported in the EU/EEA, 2007-2011 2.6.1 Antimicrobial resistance markers in microorganisms reported in healthcare-associated infections, EU/EEA (ECDC PPS), 2011-2012 2.6.2 Number of reported operations by country and type of operation, EU/EEA, 2011 2.6.3 Intubation-associated pneumonia rates by country, patient-based surveillance, EU/EEA, 2011 2.6.4 Percentages of the ten most frequently isolated microorganisms in ICU-acquired pneumonia episodes by country, EU/EEA, 2011 2.6.5 Percentages of the ten most frequently isolated microorganisms in ICU-acquired bloodstream infections by country, EU/EEA, 2011 2.6.6 Percentages of the ten most frequently isolated microorganisms in ICU-acquired urinary tract infections by country, EU/EEA, 2011